HighMark Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-400
| Closed | -$3K | – | 566 |
|
2022
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 405 |
|
2022
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 412 |
|
2022
Q1 | $4K | Hold |
400
| – | – | ﹤0.01% | 396 |
|
2021
Q4 | $3K | Sell |
400
-1,682
| -81% | -$12.6K | ﹤0.01% | 419 |
|
2021
Q3 | $20K | Buy |
2,082
+84
| +4% | +$807 | 0.01% | 182 |
|
2021
Q2 | $20K | Sell |
1,998
-672
| -25% | -$6.73K | 0.01% | 188 |
|
2021
Q1 | $31K | Sell |
2,670
-644
| -19% | -$7.48K | 0.02% | 138 |
|
2020
Q4 | $32K | Sell |
3,314
-6,093
| -65% | -$58.8K | 0.03% | 129 |
|
2020
Q3 | $85K | Buy |
9,407
+7,252
| +337% | +$65.5K | 0.08% | 72 |
|
2020
Q2 | $27K | Buy |
2,155
+846
| +65% | +$10.6K | 0.03% | 114 |
|
2020
Q1 | $11K | Hold |
1,309
| – | – | 0.01% | 147 |
|
2019
Q4 | $12K | Buy |
+1,309
| New | +$12K | 0.01% | 180 |
|